Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Dermatology

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 83 articles:
HTML format
Text format



Single Articles


    October 2018
  1. RAVINDRAN MENON D, Luo Y, Arcaroli JJ, Liu S, et al
    CDK1 interacts with Sox2 and promotes tumor initiation in human melanoma.
    Cancer Res. 2018 Oct 8. pii: 0008-5472.CAN-18-0330.
    PubMed     Text format     Abstract available


    September 2018
  2. DIKSHIT A, Jin YJ, Degan S, Hwang J, et al
    UBE2N promotes melanoma growth via MEK/FRA1/SOX10 signaling.
    Cancer Res. 2018 Sep 17. pii: 0008-5472.CAN-18-1040.
    PubMed     Text format     Abstract available


  3. PICH C, Meylan P, Mastelic-Gavillet B, Nguyen NT, et al
    Induction of paracrine signaling in metastatic melanoma cells by PPARgamma agonist rosiglitazone activates stromal cells and enhances tumor growth.
    Cancer Res. 2018 Sep 5. pii: 0008-5472.CAN-18-0912.
    PubMed     Text format     Abstract available


    August 2018
  4. HILLER B, Hoppe A, Haase C, Hiller C, et al
    Ribonucleotide excision repair is essential to prevent squamous cell carcinoma of the skin.
    Cancer Res. 2018 Aug 28. pii: 0008-5472.CAN-18-1099.
    PubMed     Text format     Abstract available


  5. THRANE K, Eriksson H, Maaskola J, Hansson J, et al
    Spatially resolved transcriptomics enables dissection of genetic heterogeneity in stage III cutaneous malignant melanoma.
    Cancer Res. 2018 Aug 28. pii: 0008-5472.CAN-18-0747.
    PubMed     Text format     Abstract available


  6. CAPPARELLI C, Purwin TJ, Heilman SA, Chervoneva I, et al
    ErbB3 targeting enhances the effects of MEK inhibitor in wild-type BRAF/NRAS melanoma.
    Cancer Res. 2018 Aug 16. pii: 0008-5472.CAN-18-1001.
    PubMed     Text format     Abstract available


  7. HUANG M, Qi TF, Li L, Zhang G, et al
    A targeted quantitative proteomic approach assesses the reprogramming of small GTPases during melanoma metastasis.
    Cancer Res. 2018 Aug 2. pii: 0008-5472.CAN-17-3811.
    PubMed     Text format     Abstract available


    July 2018
  8. VISHNOI M, Boral D, Liu H, Sprouse ML, et al
    Targeting USP7 identifies a metastasis-competent state within bone marrow-resident melanoma CTCs.
    Cancer Res. 2018 Jul 19. pii: 0008-5472.CAN-18-0644.
    PubMed     Text format     Abstract available


  9. SHABANEH TB, Molodtsov A, Steinberg SM, Zhang P, et al
    Oncogenic BRAFV600E governs regulatory T cell recruitment during melanoma tumorigenesis.
    Cancer Res. 2018 Jul 19. pii: 0008-5472.CAN-18-0365.
    PubMed     Text format     Abstract available


    June 2018
  10. WANG L, Felts SJ, Van Keulen VP, Scheid AD, et al
    Integrative genome-wide analysis of long noncoding RNAs in diverse immune cell types of melanoma patients.
    Cancer Res. 2018 Jun 12. pii: 0008-5472.CAN-18-0529.
    PubMed     Text format     Abstract available


    May 2018
  11. HUERGO ZAPICO L, Parodi M, Cantoni C, Lavarello C, et al
    NK cell editing mediates Epithelial to Mesenchymal Transition via phenotypic and proteomic changes in melanoma cell lines.
    Cancer Res. 2018 May 11. pii: 0008-5472.CAN-17-1891.
    PubMed     Text format     Abstract available


    February 2018
  12. HOULES T, Gravel SP, Lavoie G, Shin S, et al
    RSK Regulates PFK-2 Activity to Promote Metabolic Rewiring in Melanoma.
    Cancer Res. 2018 Feb 12. pii: 0008-5472.CAN-17-2215.
    PubMed     Text format     Abstract available


    January 2018
  13. UNBEKANDT M, Belshaw S, Bower J, Clarke M, et al
    Discovery of potent and selective MRCK inhibitors with therapeutic effect on skin cancer.
    Cancer Res. 2018 Jan 30. pii: 0008-5472.CAN-17-2870.
    PubMed     Text format     Abstract available


    December 2017
  14. SHARMA C, Wang HX, Li Q, Knoblich K, et al
    Protein Acyltransferase DHHC3 Regulates Breast Tumor Growth, Oxidative Stress, and Senescence.
    Cancer Res. 2017;77:6880-6890.
    PubMed     Text format     Abstract available


  15. DIAZ-MARTINEZ M, Benito-Jardon L, Alonso L, Koetz-Ploch L, et al
    miR-204-5p and miR-211-5p contribute to BRAF inhibitor resistance in melanoma.
    Cancer Res. 2017 Dec 11. pii: 0008-5472.CAN-17-1318.
    PubMed     Text format     Abstract available


    November 2017
  16. EMERSON MA, Banegas MP, Chawla N, Achacoso N, et al
    Disparities in Prostate, Lung, Breast, and Colorectal Cancer Survival and Comorbidity Status among Urban American Indians and Alaskan Natives.
    Cancer Res. 2017 Nov 29. pii: 0008-5472.CAN-17-0429.
    PubMed     Text format     Abstract available


  17. WANG G, Mustafi S, Camarena V, Volmar CH, et al
    Vitamin C sensitizes melanoma to BET inhibitors.
    Cancer Res. 2017 Nov 27. pii: 0008-5472.CAN-17-2040.
    PubMed     Text format     Abstract available


  18. BRIGHTON HE, Angus SP, Bo T, Roques J, et al
    New mechanisms of resistance to MEK inhibitors in melanoma revealed by intravital imaging.
    Cancer Res. 2017 Nov 27. pii: 0008-5472.CAN-17-1653.
    PubMed     Text format     Abstract available


  19. MO X, Zhang H, Preston S, Martin K, et al
    Interferon-2; signaling in melanocytes and melanoma cells regulates expression of CTLA-4.
    Cancer Res. 2017 Nov 17. pii: canres.1615.2017.
    PubMed     Text format     Abstract available


  20. PALMER JR, Castro-Webb N, Bertrand K, Bethea TN, et al
    Type II Diabetes and Incidence of Estrogen Receptor Negative Breast Cancer in African American Women.
    Cancer Res. 2017;77:6462-6469.
    PubMed     Text format     Abstract available


  21. HUANG WY, Lai SF, Chiu HY, Chang M, et al
    Mobilizing Transit-Amplifying Cell-Derived Ectopic Progenitors Prevents Hair Loss from Chemotherapy or Radiation Therapy.
    Cancer Res. 2017;77:6083-6096.
    PubMed     Text format     Abstract available


  22. VENTURA J, Lobachevsky PN, Palazzolo JS, Forrester H, et al
    Localized Synchrotron Irradiation of Mouse Skin Induces Persistent Systemic Genotoxic and Immune Responses.
    Cancer Res. 2017 Nov 7. doi: 10.1158/0008-5472.CAN-17-1066.
    PubMed     Text format     Abstract available


  23. HUA KT, Hong JB, Sheen YS, Huang HY, et al
    MicroRNA-519d promotes melanoma progression by downregulating EphA4.
    Cancer Res. 2017 Nov 1. pii: canres.1933.2017.
    PubMed     Text format     Abstract available


    October 2017
  24. BLATTNER C, Fleming V, Weber R, Himmelhan BS, et al
    CCR5+ myeloid-derived suppressor cells are enriched and activated in melanoma lesions.
    Cancer Res. 2017 Oct 31. pii: canres.0348.2017.
    PubMed     Text format     Abstract available


  25. LI Y, Zhong C, Liu D, Yu W, et al
    Evidence for Kaposi's Sarcoma originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition.
    Cancer Res. 2017 Oct 24. pii: canres.1961.2017.
    PubMed     Text format     Abstract available


  26. TURCOTTE M, Allard D, Mittal D, Bareche Y, et al
    CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy.
    Cancer Res. 2017;77:5652-5663.
    PubMed     Text format     Abstract available


  27. COUNTER CM, Crowe MS, Greenberg DN, Brady DC, et al
    Copper Chelation Inhibits BRAFV600E-driven Melanomagenesis and Counters Resistance to BRAFV600E and MEK1/2 Inhibitors.
    Cancer Res. 2017 Oct 6. pii: canres.1190.2016.
    PubMed     Text format     Abstract available


  28. CHANG CH, Wang Y, Li R, Rossi DL, et al
    Combination Therapy with Bispecific Antibodies and PD-1 Blockade Enhances the Antitumor Potency of T Cells.
    Cancer Res. 2017;77:5384-5394.
    PubMed     Text format     Abstract available


  29. GALL VA, Philips AV, Qiao N, Clise-Dwyer K, et al
    Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells.
    Cancer Res. 2017;77:5374-5383.
    PubMed     Text format     Abstract available


  30. CANEL M, Byron A, Sims AH, Cartier J, et al
    Nuclear FAK and Runx1 Cooperate to Regulate IGFBP3, Cell-Cycle Progression, and Tumor Growth.
    Cancer Res. 2017;77:5301-5312.
    PubMed     Text format     Abstract available


    September 2017
  31. LI J, Yan S, Liu Z, Zhou Y, et al
    Multiregional sequencing reveals genomic alterations and clonal dynamics in primary malignant melanoma of the esophagus.
    Cancer Res. 2017 Sep 29. pii: canres.0938.2017.
    PubMed     Text format     Abstract available


  32. ISHIHARA S, Inman DR, Li WJ, Ponik SM, et al
    Mechano-signal transduction in mesenchymal stem cells induces prosaposin secretion to drive the proliferation of breast cancer cells.
    Cancer Res. 2017 Sep 28. pii: canres.0569.2017.
    PubMed     Text format     Abstract available


  33. YANG A, Qin S, Schulte BA, Ethier SP, et al
    MYC Inhibition depletes cancer stem-like cells in triple-negative breast cancer.
    Cancer Res. 2017 Sep 26. pii: canres.3452.2016.
    PubMed     Text format     Abstract available


  34. WANG JY, Liu GZ, Wilmott JS, La T, et al
    Skp2-mediated stabilization of MTH1 promotes survival of melanoma cells upon oxidative stress.
    Cancer Res. 2017 Sep 25. pii: canres.1965.2017.
    PubMed     Text format     Abstract available


  35. NEISWENDER JV, Kortum RL, Bourque C, Kasheta M, et al
    KIT suppresses BRAFV600E-mutant melanoma by attenuating oncogenic RAS/MAPK signaling.
    Cancer Res. 2017 Sep 25. pii: canres.0473.2017.
    PubMed     Text format     Abstract available


  36. TEO ZL, Versaci S, Dushyanthen S, Caramia F, et al
    Combined CDK4/6 and PI3Kalpha inhibition is synergistic and immunogenic in triple negative breast cancer.
    Cancer Res. 2017 Sep 25. pii: canres.2210.2017.
    PubMed     Text format     Abstract available


  37. CHEN L, Chubak J, Boudreau DM, Barlow WE, et al
    Diabetes treatments and risks of adverse breast cancer outcomes among early stage breast cancer patients: A SEER-Medicare analysis.
    Cancer Res. 2017 Sep 21. pii: canres.0687.2017.
    PubMed     Text format     Abstract available


  38. DAVIES H, Morganella S, Purdie CA, Jang SJ, et al
    Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency.
    Cancer Res. 2017;77:4755-4762.
    PubMed     Text format     Abstract available


  39. TAKADA M, Zhang W, Suzuki A, Kuroda TS, et al
    FBW7 Loss Promotes Chromosomal Instability and Tumorigenesis via Cyclin E1/CDK2-Mediated Phosphorylation of CENP-A.
    Cancer Res. 2017;77:4881-4893.
    PubMed     Text format     Abstract available


  40. SI Y, Ji X, Cao X, Dai X, et al
    Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.
    Cancer Res. 2017;77:4868-4880.
    PubMed     Text format     Abstract available


  41. TOLOCZKO A, Guo F, Yuen HF, Wen Q, et al
    Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.
    Cancer Res. 2017;77:4921-4933.
    PubMed     Text format     Abstract available


  42. SAMPSON J, O'Regan L, Dyer MJS, Bayliss R, et al
    Hsp72 and Nek6 Cooperate to Cluster Amplified Centrosomes in Cancer Cells.
    Cancer Res. 2017;77:4785-4796.
    PubMed     Text format     Abstract available


  43. SONG KH, Choi CH, Lee HJ, Oh SJ, et al
    HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells.
    Cancer Res. 2017;77:5039-5053.
    PubMed     Text format     Abstract available


  44. MCFARLAND CD, Yaglom JA, Wojtkowiak JW, Scott JG, et al
    The Damaging Effect of Passenger Mutations on Cancer Progression.
    Cancer Res. 2017;77:4763-4772.
    PubMed     Text format     Abstract available


  45. KATZENELLENBOGEN BS, Zhao Y, Laws MJ, Sanabria Guillen V, et al
    Structurally novel antiestrogens elicit differential responses from constitutively active mutant estrogen receptors in breast cancer cells and tumors.
    Cancer Res. 2017 Sep 13. pii: canres.1265.2017.
    PubMed     Text format     Abstract available


  46. NDOYE A, Budina-Kolomets A, Kugel CH, Webster MR, et al
    ATG5 mediates a positive feedback loop between Wnt signaling and autophagy in melanoma.
    Cancer Res. 2017 Sep 8. pii: canres.0907.2017.
    PubMed     Text format     Abstract available


  47. DETHLEFSEN C, Hansen LS, Lillelund C, Andersen C, et al
    Exercise-Induced Catecholamines Activate the Hippo Tumor Suppressor Pathway to Reduce Risks of Breast Cancer Development.
    Cancer Res. 2017 Sep 8. doi: 10.1158/0008-5472.CAN-16-3125.
    PubMed     Text format     Abstract available


  48. METZGER E, Stepputtis SS, Strietz J, Preca BT, et al
    KDM4 inhibition targets breast cancer stem-like cells.
    Cancer Res. 2017 Sep 7. pii: canres.1754.2017.
    PubMed     Text format     Abstract available


  49. RIOS-LUCI C, Garcia-Alonso S, Diaz-Rodriguez E, Nadal-Serrano M, et al
    Resistance to the Antibody-Drug Conjugate T-DM1 Is Based in a Reduction in Lysosomal Proteolytic Activity.
    Cancer Res. 2017;77:4639-4651.
    PubMed     Text format     Abstract available


    August 2017
  50. ROSS MH, Esser AK, Fox GC, Schmieder AH, et al
    Bone-induced expression of integrin beta3 enables targeted nanotherapy of breast cancer metastases.
    Cancer Res. 2017 Aug 30. pii: canres.1225.2017.
    PubMed     Text format     Abstract available


  51. LI J, Gao Z, Zhao D, Zhang L, et al
    PI-273, a substrate-competitive, specific small molecule inhibitor of PI4KIIalpha, inhibits the growth of breast cancer cells.
    Cancer Res. 2017 Aug 21. pii: canres.0484.2017.
    PubMed     Text format     Abstract available


  52. WANG YW, Reder NP, Kang S, Glaser AK, et al
    Raman-Encoded Molecular Imaging with Topically Applied SERS Nanoparticles for Intraoperative Guidance of Lumpectomy.
    Cancer Res. 2017;77:4506-4516.
    PubMed     Text format     Abstract available


  53. JDEY W, Thierry S, Popova T, Stern MH, et al
    Micronuclei Frequency in Tumors Is a Predictive Biomarker for Genetic Instability and Sensitivity to the DNA Repair Inhibitor AsiDNA.
    Cancer Res. 2017;77:4207-4216.
    PubMed     Text format     Abstract available


  54. SAHNI JM, Gayle SS, Webb B, Weber-Bonk KL, et al
    Mitotic vulnerability in triple-negative breast cancer associated with LIN9 is targetable with BET inhibitors.
    Cancer Res. 2017 Aug 14. pii: canres.1571.2017.
    PubMed     Text format     Abstract available


  55. CHAN CHT, Munusamy P, Loke SY, Koh GL, et al
    Identification of Novel Breast Cancer Risk Loci.
    Cancer Res. 2017 Aug 3. pii: canres.0992.2017.
    PubMed     Text format     Abstract available


  56. ZAMOISKI RD, Yanik E, Gibson TM, Cahoon EK, et al
    Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers.
    Cancer Res. 2017;77:4196-4203.
    PubMed     Text format     Abstract available


  57. ZOU X, Zhu Y, Park SH, Liu G, et al
    SIRT3-Mediated Dimerization of IDH2 Directs Cancer Cell Metabolism and Tumor Growth.
    Cancer Res. 2017;77:3990-3999.
    PubMed     Text format     Abstract available


  58. DONGRE A, Rashidian M, Reinhardt F, Bagnato A, et al
    Epithelial-to-Mesenchymal Transition Contributes to Immunosuppression in Breast Carcinomas.
    Cancer Res. 2017;77:3982-3989.
    PubMed     Text format     Abstract available


    July 2017
  59. REGGIANI F, Labanca V, Mancuso P, Rabascio C, et al
    Adipose progenitor cell secretion of GM-CSF and MMP9 promotes a stromal and immunological microenvironment that supports breast cancer progression.
    Cancer Res. 2017 Jul 28. pii: canres.0914.2017.
    PubMed     Text format     Abstract available


  60. FINLAY-SCHULTZ J, Gillen AE, Brechbuhl HM, Ivie JJ, et al
    Breast cancer suppression by progesterone receptors is mediated by their modulation of estrogen receptors and RNA polymerase III.
    Cancer Res. 2017 Jul 20. pii: canres.3541.2016.
    PubMed     Text format     Abstract available


  61. SALVADOR F, Martin A, Lopez-Menendez C, Moreno-Bueno G, et al
    Lysyl oxidase-like protein LOXL2 promotes lung metastasis of breast cancer.
    Cancer Res. 2017 Jul 18. pii: canres.3152.2016.
    PubMed     Text format     Abstract available


  62. JERMYN M, Mercier J, Aubertin K, Desroches J, et al
    Highly Accurate Detection of Cancer In Situ with Intraoperative, Label-Free, Multimodal Optical Spectroscopy.
    Cancer Res. 2017;77:3942-3950.
    PubMed     Text format     Abstract available


  63. LIU S, Cheng C
    Akt Signaling Is Sustained by a CD44 Splice Isoform-Mediated Positive Feedback Loop.
    Cancer Res. 2017;77:3791-3801.
    PubMed     Text format     Abstract available


  64. SOSSEY-ALAOUI K, Pluskota E, Bialkowska K, Szpak D, et al
    Kindlin-2 regulates the growth of breast cancer tumors by activating CSF-1-mediated macrophage infiltration.
    Cancer Res. 2017 Jul 7. pii: canres.2337.2016.
    PubMed     Text format     Abstract available


  65. CASIMIRO MC, Di Sante G, Di Rocco A, Loro E, et al
    Cyclin D1 Restrains Oncogene-Induced Autophagy by Regulating the AMPK-LKB1 Signaling Axis.
    Cancer Res. 2017;77:3391-3405.
    PubMed     Text format     Abstract available


  66. NIE Y, Chen J, Huang D, Yao Y, et al
    Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation.
    Cancer Res. 2017;77:3605-3618.
    PubMed     Text format     Abstract available


    June 2017
  67. YOU E, Huh YH, Kwon A, Kim SH, et al
    SPIN90 depletion and Microtubule Acetylation Mediate Stromal Fibroblast Activation in Breast Cancer Progression.
    Cancer Res. 2017 Jun 26. pii: canres.0657.2017.
    PubMed     Text format     Abstract available


  68. SALEH SM, Bertos NR, Gruosso T, Gigoux M, et al
    Identification of interacting stromal axes in triple-negative breast cancer.
    Cancer Res. 2017 Jun 26. pii: canres.3427.2016.
    PubMed     Text format     Abstract available


  69. VERHAEGEN ME, Mangelberger D, Harms PW, Eberl M, et al
    Merkel Cell Polyomavirus Small T Antigen Initiates Merkel Cell Carcinoma-like Tumor Development in Mice.
    Cancer Res. 2017;77:3151-3157.
    PubMed     Text format     Abstract available


  70. HUMPHRIES B, Wang Z, Li Y, Jhan JR, et al
    ARHGAP18 downregulation by miR-200b suppresses metastasis of triple negative breast cancer by enhancing activation of RhoA.
    Cancer Res. 2017 Jun 15. pii: canres.3141.2016.
    PubMed     Text format     Abstract available


  71. FLOWERS M, Birkey Reffey S, Mertz SA, Hurlbert M, et al
    Obstacles, Opportunities and Priorities for Advancing Metastatic Breast Cancer Research.
    Cancer Res. 2017 Jun 10. doi: 10.1158/0008-5472.CAN-17-0232.
    PubMed     Text format     Abstract available


  72. BAN Y, Mai J, Li X, Mitchell-Flack M, et al
    Targeting Autocrine CCL5-CCR5 Axis Reprograms Immunosuppressive Myeloid Cells and Reinvigorates Antitumor Immunity.
    Cancer Res. 2017;77:2857-2868.
    PubMed     Text format     Abstract available


    May 2017
  73. VALDEZ KE, Elsarraj HS, Hong Y, Grimm SL, et al
    NEMO, a transcriptional target of estrogen and progesterone, is linked to tumor suppressor PML in breast cancer.
    Cancer Res. 2017 May 17. pii: canres.2794.2016.
    PubMed     Text format     Abstract available


  74. BARTON VN, Christenson JL, Gordon MA, Greene LI, et al
    Androgen receptor supports an anchorage-independent, cancer stem cell-like population in triple-negative breast cancer.
    Cancer Res. 2017 May 16. pii: canres.3240.2016.
    PubMed     Text format     Abstract available


  75. HOLM J, Eriksson L, Ploner A, Eriksson M, et al
    Assessment of breast cancer risk factors reveals subtype heterogeneity.
    Cancer Res. 2017 May 16. pii: canres.2574.2016.
    PubMed     Text format     Abstract available


  76. ROSSI EL, Dunlap SM, Bowers LW, Khatib SA, et al
    Energy Balance Modulation Impacts Epigenetic Reprogramming, ERalpha and ERbeta Expression, and Mammary Tumor Development in MMTV-neu Transgenic Mice.
    Cancer Res. 2017;77:2500-2511.
    PubMed     Text format     Abstract available


    April 2017
  77. LI B, Ni Chonghaile T, Fan Y, Madden S, et al
    THERAPEUTIC RATIONALE TO TARGET HIGHLY EXPRESSED CDK7 CONFERRING POOR OUTCOMES IN TRIPLE-NEGATIVE BREAST CANCER.
    Cancer Res. 2017 Apr 28. pii: canres.2546.2016.
    PubMed     Text format     Abstract available


  78. SAFONOV A, Jiang T, Bianchini G, Gyorffy B, et al
    Immune gene expression is associated with genomic aberrations in breast cancer.
    Cancer Res. 2017 Apr 20. pii: canres.3478.2016.
    PubMed     Text format     Abstract available


  79. LU K, Alcivar AL, Ma J, Foo TK, et al
    NRF2 induction supporting breast cancer cell survival is enabled by oxidative stress-induced DPP3-KEAP1 interaction.
    Cancer Res. 2017 Apr 17. pii: canres.2204.2016.
    PubMed     Text format     Abstract available


  80. GAGGIANESI M, Turdo A, Chinnici A, Lipari E, et al
    IL-4 primes the dynamics of breast cancer progression via DUSP4 inhibition.
    Cancer Res. 2017 Apr 11. pii: canres.3126.2016.
    PubMed     Text format     Abstract available


  81. HANKER AB, Estrada MV, Bianchini G, Moore PD, et al
    Extracellular matrix/integrin signaling promotes resistance to combined inhibition of HER2 and PI3K in HER2+ breast cancer.
    Cancer Res. 2017 Apr 10. pii: canres.2808.2016.
    PubMed     Text format     Abstract available


    March 2017
  82. TEMKO DP, Cheng YK, Polyak K, Michor F, et al
    Mathematical modeling links pregnancy-associated changes and breast cancer risk.
    Cancer Res. 2017 Mar 30. pii: canres.2504.2016.
    PubMed     Text format     Abstract available


  83. SHIMELIS H, Mesman RL, Von Nicolai C, Ehlen A, et al
    BRCA2 hypomorphic missense variants confer moderate risks of breast cancer.
    Cancer Res. 2017 Mar 10. pii: canres.2568.2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dermatology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: